ReconSpine

FDA grants Centinel Spine allogeneic bone graft indications for lumbar spinal fusion line — 5 key notes

By Laura Dyrda

Centinel Spine received an allogeneic bone graft indication for its anterior lumbar product family.

Here are five things to know:

1. The FDA cleared the STALIF MIDLINE, MIDLINE II and MIDLINE II-Ti (Ti-ACTIVE) devices for use with allogeneic bone graft in lumbar spinal fusions.

2. The Centinel Spine standalone devices have a no-profile design and are integrated interbody systems for use with autograft and/or allogeneic bone graft in lumbar and cervical fusion procedures.

READ MORE HERE

Related Articles

Back to top button